Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect and Bioavailability of Ibuprofen CR 600 mg in Healthy Volunteers
NCT03418805Phase 1Terminated
- Sponsor
- Overseas Pharmaceuticals
- Start
- Dec 2017
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ibuprofen in pain (4 arms), sponsored by Overseas Pharmaceuticals. Primary endpoints: Area under the curve from time zero to the time of the last quantifiable plasma concentration at 1 month, Area under the curve from time zero to infinity at 1 month and 1 more. Started Dec 2017; status: terminated.
02
Drugs
ibuprofen
03
Conditions
pain
Beyond the preview
Go deeper on NCT03418805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03418805.